Generation of bone marrow chimeras using X-ray irradiation: comparison to cesium irradiation and use in immunotherapy
Main Article Content
Keywords
immunotherapy, bone marrow chimera, X-ray irradiation, cesium irradiation, tumor model, syngeneic
Abstract
Bone marrow chimeras represent a key tool employed to understand biological contributions stemming from the hematopoietic versus the stromal compartment. In most institutions, cesium irradiators are used to lethally irradiate recipient animals prior to the injection of donor bone marrow. Cesium irradiators, however, have significant liabilities—including concerns around domestic security. Recently, X-ray irradiators have been implemented as a potential alternative to cesium sources. Only a small number of publications in the literature have attempted to compare these two modalities and, in most cases, the emphasis was on irradiation of human blood productions. We were able to find only a single study that directly compared X-ray and cesium technologies in the generation of murine bone marrow chimeras, a standard laboratory practice. This study focused on chimerism in the blood of recipient animals. In the present study, we begin by comparing cesium and X-ray based sources for irradiation, then transition to using X-ray-based systems for immunology models with an emphasis on immunotherapy of cancer in immunocompetent mouse models—specifically evaluating chimerism in the blood, spleen, and tumor microenvironment. While our data demonstrate that the two platforms are functionally comparable and suggest that X-ray based technology is a suitable alternative to cesium sources. We also highlight a difference in chimerism between the peripheral (blood, spleen) and tumor compartments that is observed using both technologies. While the overall degree of chimerism in the peripheral tissues is very high, the degree of chimerism in the tumor is cell type specific with T and NK cells showing lower chimerism than other cell types.
Downloads
Metrics
References
2. Janatpour, K., et al., Comparison of X-ray vs. gamma irradiation of CPDA-1 red cells. Vox Sang, 2005. 89(4): p. 215-9.
3. Gibson, B.W., et al., Comparison of Cesium-137 and X-ray Irradiators by Using Bone Marrow Transplant Reconstitution in C57BL/6J Mice. Comp Med, 2015. 65(3): p. 165-72.
4. Spangrude, G.J., Assessment of lymphocyte development in radiation bone marrow chimeras. Curr Protoc Immunol, 2001. Chapter 4: p. Unit 4 6.
5. Tollefson, J., Biologists struggle with push to eliminate radioactive caesium in labs. Nature, 2016. 533(7602): p. 156-7.
6. Amend, S.R., K.C. Valkenburg, and K.J. Pienta, Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation. J Vis Exp, 2016(110).
7. Bosco, N., et al., Auto-reconstitution of the T-cell compartment by radioresistant hematopoietic cells following lethal irradiation and bone marrow transplantation. Exp Hematol, 2010. 38(3): p. 222-232 e2.
8. Dummer, W., et al., T cell homeostatic proliferation elicits effective antitumor autoimmunity. J Clin Invest, 2002. 110(2): p. 185-92.
9. Selby, M.J., et al., Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells. Cancer Immunol Res, 2013. 1(1): p. 32-42.
10. Selby, M.J., et al., Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology. PLoS One, 2016. 11(9): p. e0161779.
11. Ballinger, M.N., et al., IRAK-M promotes alternative macrophage activation and fibroproliferation in bleomycin-induced lung injury. J Immunol, 2015. 194(4): p. 1894-904.
12. Hollingsworth, J.W., et al., Both hematopoietic-derived and non-hematopoietic-derived {beta}-arrestin-2 regulates murine allergic airway disease. Am J Respir Cell Mol Biol, 2010. 43(3): p. 269-75.
13. Huang, W., et al., A Novel Pkhd1 Mutation Interacts with the Nonobese Diabetic Genetic Background To Cause Autoimmune Cholangitis. J Immunol, 2018. 200(1): p. 147-162.
14. Hwang, S., et al., Blimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis. J Exp Med, 2016. 213(9): p. 1799-818.
15. Komada, T., et al., Macrophage Uptake of Necrotic Cell DNA Activates the AIM2 Inflammasome to Regulate a Proinflammatory Phenotype in CKD. J Am Soc Nephrol, 2018. 29(4): p. 1165-1181.
16. Kronenberg, G., et al., Distinguishing features of microglia- and monocyte-derived macrophages after stroke. Acta Neuropathol, 2018. 135(4): p. 551-568.
17. Machein, M.R. and K.H. Plate, Bone marrow chimera experiments to determine the contribution of hematopoietic stem cells to cerebral angiogenesis. Methods Mol Biol, 2014. 1135: p. 275-88.
18. Majorov, K.B., et al., Analysis of cellular phenotypes that mediate genetic resistance to tuberculosis using a radiation bone marrow chimera approach. Infect Immun, 2005. 73(9): p. 6174-8.
19. Micklem, H.S., et al., Fate of chromosome-marked mouse bone marrow cells tranfused into normal syngeneic recipients. Transplantation, 1968. 6(2): p. 299-302.
20. Milas, L., et al., Retardation of tumor growth in mice caused by radiation-induced injury of tumor bed stroma: dependency on tumor type. Cancer Res, 1986. 46(2): p. 723-7.
21. McBride, W.H., et al., A sense of danger from radiation. Radiat Res, 2004. 162(1): p. 1-19.
Article Sidebar
Article Details
Authors who publish with JBM agree to the following terms:
- Authors retain copyright and grant JBM right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Jason DeVoss, Amgen Research
Principal Scientist, Amgen Research, Oncology and Inflammation
